UY27661A1 - Derivados de benzimidazol 1-fenil-2-heteroaril-sustituidos, su uso para preparar medicamentos y preparados farmacéuticos que los contienen. - Google Patents

Derivados de benzimidazol 1-fenil-2-heteroaril-sustituidos, su uso para preparar medicamentos y preparados farmacéuticos que los contienen.

Info

Publication number
UY27661A1
UY27661A1 UY27661A UY27661A UY27661A1 UY 27661 A1 UY27661 A1 UY 27661A1 UY 27661 A UY27661 A UY 27661A UY 27661 A UY27661 A UY 27661A UY 27661 A1 UY27661 A1 UY 27661A1
Authority
UY
Uruguay
Prior art keywords
derivatives
pharmaceutical preparations
heteroaril
fenil
benzimidazol
Prior art date
Application number
UY27661A
Other languages
English (en)
Inventor
Thorsten Blume
Wolfgang Halfbrodt
Joachin Kuhnke
Ursula Monning
Bernd Elger
Herbert Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY27661A1 publication Critical patent/UY27661A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos derivados de benzimidazol, su preparación y su uso para preparar medicamentos para el tratamiento y la profilaxis de enfermedades que están asociadas con una activación de la microglía, y enfermedades inmunológicas mediatas por células T, así como preparados farmacéuticos que contienen los nuevos derivados de bezimidazol.
UY27661A 2002-02-15 2003-02-11 Derivados de benzimidazol 1-fenil-2-heteroaril-sustituidos, su uso para preparar medicamentos y preparados farmacéuticos que los contienen. UY27661A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10207844A DE10207844A1 (de) 2002-02-15 2002-02-15 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
UY27661A1 true UY27661A1 (es) 2003-09-30

Family

ID=27674913

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27661A UY27661A1 (es) 2002-02-15 2003-02-11 Derivados de benzimidazol 1-fenil-2-heteroaril-sustituidos, su uso para preparar medicamentos y preparados farmacéuticos que los contienen.

Country Status (30)

Country Link
EP (1) EP1474415B1 (es)
JP (1) JP4739675B2 (es)
KR (1) KR101027556B1 (es)
CN (1) CN1317274C (es)
AR (1) AR038492A1 (es)
AT (1) ATE517881T1 (es)
AU (1) AU2003205624B2 (es)
BR (1) BR0307723A (es)
CA (1) CA2475780C (es)
CR (1) CR7442A (es)
CY (1) CY1113230T1 (es)
DE (1) DE10207844A1 (es)
DK (1) DK1474415T3 (es)
EC (1) ECSP045296A (es)
ES (1) ES2369662T3 (es)
IL (1) IL163431A (es)
MX (1) MXPA04007949A (es)
NO (1) NO329667B1 (es)
NZ (1) NZ534660A (es)
PE (1) PE20030941A1 (es)
PL (1) PL216233B1 (es)
PT (1) PT1474415E (es)
RS (1) RS51831B (es)
RU (1) RU2325384C2 (es)
SI (1) SI1474415T1 (es)
TW (1) TWI328583B (es)
UA (1) UA81243C2 (es)
UY (1) UY27661A1 (es)
WO (1) WO2003068766A1 (es)
ZA (1) ZA200407381B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1497266T3 (da) 2002-03-27 2008-10-06 Glaxo Group Ltd Quinolinderivater og deres anvendelse som 5HT6-ligander
CN1787817B (zh) * 2003-05-19 2011-09-07 Irm责任有限公司 免疫抑制剂化合物及组合物
WO2014044611A1 (en) 2012-09-20 2014-03-27 Bayer Pharma Aktiengesellschaft 1-aryl-2-heteroaryl benzimidazoles for the induction of neuronal regeneration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
MXPA02005742A (es) 2000-01-14 2002-09-18 Schering Ag 1,2-diaril bencimidazoles para el tratamiento de enfermedades asociadas con la activacion de la micrologia.
US7115645B2 (en) * 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
DE10207843A1 (de) * 2002-02-15 2003-09-04 Schering Ag Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen

Also Published As

Publication number Publication date
TW200303307A (en) 2003-09-01
SI1474415T1 (sl) 2011-12-30
RU2004127678A (ru) 2005-07-10
CY1113230T1 (el) 2016-04-13
WO2003068766A1 (de) 2003-08-21
BR0307723A (pt) 2005-01-25
KR101027556B1 (ko) 2011-04-06
IL163431A (en) 2010-11-30
UA81243C2 (en) 2007-12-25
RS51831B (en) 2012-02-29
JP4739675B2 (ja) 2011-08-03
RS71404A (en) 2006-10-27
CN1633429A (zh) 2005-06-29
ZA200407381B (en) 2005-11-30
KR20040081795A (ko) 2004-09-22
TWI328583B (en) 2010-08-11
AU2003205624B2 (en) 2009-08-27
JP2005521686A (ja) 2005-07-21
CA2475780C (en) 2011-08-02
ATE517881T1 (de) 2011-08-15
CR7442A (es) 2006-02-06
AR038492A1 (es) 2005-01-19
PL216233B1 (pl) 2014-03-31
ECSP045296A (es) 2004-10-26
CA2475780A1 (en) 2003-08-21
EP1474415B1 (de) 2011-07-27
DE10207844A1 (de) 2003-09-04
DK1474415T3 (da) 2011-11-21
RU2325384C2 (ru) 2008-05-27
CN1317274C (zh) 2007-05-23
PL371269A1 (en) 2005-06-13
PT1474415E (pt) 2011-10-13
NO329667B1 (no) 2010-11-29
NZ534660A (en) 2006-02-24
EP1474415A1 (de) 2004-11-10
PE20030941A1 (es) 2004-01-17
ES2369662T3 (es) 2011-12-02
NO20043841L (no) 2004-11-12
MXPA04007949A (es) 2004-11-26
AU2003205624A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
UY29087A1 (es) Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico
CL2008001626A1 (es) Compuestos derivados de heterociclos fusionados, agente farmaceutico que los comprende y su uso en la profilaxis y tratamiento del cancer.
ECSP109935A (es) Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k
DOP2009000155A (es) Derivados de hetero-pentaciclo-fenilo fusionados, composicion farmaceutica que los comprende y usos para preparar un medicamento util para el tratamiento de una condicion mediada por p38
AR067347A1 (es) Combinacion antihelmintica
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
ECSP056194A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa
CR7716A (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
CO6390066A2 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
GT200900328A (es) Derivados de bencimidazol
CL2011003160A1 (es) Compuestos derivados de heterociclicos, moduladores cb2; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades reumaticas, autoinmune, inflamatorias, dolor, entre otras.
CR20110599A (es) Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos
UY29199A1 (es) Derivados tiazol, composiciones que los contienen, procedimientos de preparación y aplicaciones
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
BR112015018087A8 (pt) composto, composição farmacêutica e uso
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
BRPI0912411A8 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) ou de um fragmento da mesma, composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune, uso de muteína de interleucina humana-2 (muteína de hil-2) ou de uma seção da mesma, agete para formação de células t regulatórias (treg) em um organismo, método para tratamento e/ou profilaxia de uma doença autoimune em um organismo, método para formação de células t regulatórias (treg) em um organismo, método para formação de células t regulatórias (treg) in vitro.
GT201200126A (es) Derivados de la cromenona con actividad anti-tumoral
CL2008002852A1 (es) Compuestos derivados de 7-fluoro-5-metil-2-(fenilamino)-6,7,8,9-tetrahidro-5h-pirimido[4,5-b][1,4]diazepin-6(7h)-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de canceer, inflamacion, alopecia, enfermedades autoinmune, cardiovasculares, infecciosas, nefrologicas, neurodfegenerativas, cutaneas y oseas.
PA8806201A1 (es) Imidazo pirazinas fusionadas
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
CU20210003A7 (es) Una preparación farmacéutica liposomal de mitoxantrona útil en el tratamiento de linfoma no de hodgkin
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
CO6280470A2 (es) Bis-piridilpiridonas como antaginistas del receptor 1 de la hormona concentradora de la melanina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150428